Pharmaceuticals, Biotechnology and Life Sciences
VANCOUVER, British Columbia–(BUSINESS WIRE)–Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional therapeutics, today announced the appointment of Kathryn…
TriPharm services creates Pharmaceutical manufacturing center to address Shortage of qualified parenteral manufacturing options in the U.S.
Amarna Therapeutics has raised €10 million in a round led by Swedish investor Flerie Invest AB with substantial contributions from…
Vaxess and GC Pharma will collaborate on Influenza vaccine smart release patch, in a deal which will give Vaxess exclusive…
Amphivena is set to move on with AMV564 in a Multi-Center Dose Finding Phase 1 Clinical Study in Patients with…
Enzyvant appoints former COO of Compass and Horizon Discovery as Chief Operating Officer, as the company nears first potential drug…
BOSTON–(BUSINESS WIRE)–Pyxis Oncology, an immuno-oncology company focused on developing a new family of antibody-based immunotherapies derived from novel insights into…
NOXXON said Wednesday it has enrolled the first patient in phase 1/2 trial in a therapy of increasing doses of…
Ipsen and Blueprint medicines have entered a deal which expands Ipsen’s rare diseases portfolio to include BLU-782, a highly selective…
Credence got a grant from the Bill & Melinda Gates Foundation with which it plans funding will support development of…